Blog

YP-CDN Partners in Youth Innovation Lab held at WHO Financing Conference in Copenhagen, Denmark

The WHO Global Dialogue was part of the informal process leading up to the United Nations General Assembly Third High-Level Meeting on the Prevention and Control of Non-communicable Diseases in September 2018. It was co-organized by the World Health Organization and the Government of Denmark and supported by the Organisation for Economic Co-operation and Development, the World Diabetes Foundation, the International Federation of Pharmaceutical Manufacturers and Associations, the World Economic Forum and the NCD Alliance. 
 
Read more
YP-CDN Partners in Youth Innovation Lab held at WHO Financing Conference in Copenhagen, Denmark
YP-CDN Partners in Youth Innovation Lab held at WHO Financing Conference in Copenhagen, Denmark

Inappropriate prescribing among Ethiopian cardiovascular patients using STOPP/START criteria.

Cardiovascular disorders are among the leading chronic illnesses. Medications play a pivotal role to control the signs, symptoms and progression of these disorders. However, the outcome of the management is depend on the delivery of the right regimen to the right patient. A recent prospective evaluation of prescriptions among Ethiopian cardiovascular patients have identified that approximately, two-thirds of elderly cardiovascular patients encountered potentially inappropriate prescription which is more significant.  The magnitude of inappropriate prescription is aggravated by long hospital stay and large number of medications. Therefore, it is essential to evaluate patients’ medications during hospital stay to reduce the burden of potentially inappropriate prescription. Members of the young professionals’ chronic diseases network-Gondar chapter have been engaged in the acquisition, analysis and interpretation of results on this project.

Readers are advised to visit the following link to access the full text of the article.

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0195949

Inappropriate prescribing among Ethiopian cardiovascular patients using STOPP/START criteria.
Inappropriate prescribing among Ethiopian cardiovascular patients using STOPP/START criteria.

Older patients’ perception of deprescribing in resource-limited settings

As people get older, Chronic diseases become common causes of diseases, having multimorbidity. This will lead to have polypharmacy in older patients contributing to the regimen complexity which can affects patients medication adherence, prescribing quality, adverse drug reaction, health related quality of life and death. All these necessitates a clinical intervention such as deprescribing (reducing inappropriate poly-pharmacy). But such intervention should consider older patients decision/willingness in medication discontinuation process as it may affects the ultimate their clinical outcome. Though this has been extensively explored in developed countries, no attempt was made to explore willingness of older adults with chronic disease for discontinuation of inappropriate medications. 

Young Professionals Chronic Disease Network (YP-CDN) Ethiopia chapter, has worked with older patients living with chronic diseases and has identified their priorities for advocacy, and were used as an input for this research project.

Medication safety for older patients with chronic disease requires deprescription of the inappropriate prescriptions. 

Find the full article at http://bmjopen.bmj.com/content/8/4/e020590

 

Older patients’ perception of deprescribing in resource-limited settings
Older patients’ perception of deprescribing in resource-limited settings

Adherence to Novel Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-analysis

 

Novel Oral Anticoagulants (NOACs) are front line medications for the prevention of cerebrovascular accident secondary to cardio-embolism. Recently, NOACs are replacing coumarins since they do not require close monitoring. But, real world evidence was required to evaluate the extent of adherence to these agents. Accordingly, sub-optimal adherence to NOACs was noted based on evidence obtained from a meta-analysis of 1.6 million Atrial Fibrillation (AF) patients. Interventions should be promptly designed to improve the compliance of patients for NOACs. Further, the availability and affordability of these medications should be insured in developing countries to save the lives of individuals who are suffering from AF.

The finding of the study is available from the following link.  doi: 10.2174/1570161116666180123111949.

Adherence to Novel Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-analysis
Adherence to Novel Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-analysis

Read the blog at Young Professionals Chronic Disease Network
Blog
Home